• SGS expanded its Saint-Benoît bioanalytical laboratory near Poitiers, France, adding 500 m² to increase capacity for complex drug development.
• Total footprint rose to nearly 4,500 m² following the expansion, supported by renovation of existing facilities.
• Added space lifts throughput for higher sample volumes, large-scale studies, faster turnaround, spanning preclinical through clinical programs.
• Facility supports bioanalysis including small molecules, biologics, ADCs, RNA, PK/PD, immunogenicity, biomarkers under GCP and GLP standards.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SGS SA published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.